1 results match your criteria: "Arthur G James Cancer Hospital and Richard J SoloveResearch Institute[Affiliation]"
Mol Cancer Ther
February 2010
Department of Surgery, Division of Surgical Oncology, The Ohio State University, Arthur G James Cancer Hospital and Richard J SoloveResearch Institute, Columbus, Ohio 43210, USA.
Interleukin-29 (IL-29) is a member of the type III IFN family that has been shown to have antiviral activity and to inhibit cell growth. Melanoma cell lines were tested for expression of the IL-29 receptor (IL-29R) and their response to IL-29. Expression of IL-28R1 and IL-10R2, components of IL-29R, was evaluated using reverse transcription-PCR.
View Article and Find Full Text PDF